Skip to main content
Clinical Trials/NCT04918433
NCT04918433
Unknown
N/A

Comparison of Pectointercostal Block and Transverse Thoracic Plane Block for ERAS Post Congenital Cardiac Surgery

University of Alexandria1 site in 1 country60 target enrollmentJune 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Local Infiltration
Sponsor
University of Alexandria
Enrollment
60
Locations
1
Primary Endpoint
Weight, height , BMI
Last Updated
4 years ago

Overview

Brief Summary

The current study is designed to compare the perioperative analgesic efficacy of transversus thoracis plane block (TTPB) and Pecto-intercostal-fascial plane block (PIFB) in children undergoing cardiac surgery via median sternotomy

Detailed Description

Sixty paediatric patients of either sex, aged 2-12 years, undergoing elective cardiac surgery via median sternotomy. Patients will be excluded from the current study in case of, refusal to participate, redo or urgent cardiac surgery, local infection of the skin at the site of needle puncture, allergy to bupivacaine, coagulation disorders, clinically significant liver or kidney disease, heart failure, moderate to severe pulmonary hypertension, and when extubation is intentionally planned to be delayed. Patients will be randomly assigned to one of two equal groups, the PIF block group and TTP block group, each will include 30 patients, by a computer-generated randomization table and concealed sealed opaque envelopes.

Registry
clinicaltrials.gov
Start Date
June 1, 2021
End Date
July 25, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ibrahim Mabrouk Ibrahim

Assistant lecturer

University of Alexandria

Eligibility Criteria

Inclusion Criteria

  • either sex, aged 2-12 years, undergoing
  • elective cardiac surgery via median sternotomy

Exclusion Criteria

  • refusal to participate, redo or urgent cardiac surgery, local infection of the skin at the site of needle puncture, allergy to bupivacaine, coagulation disorders, clinically significant liver or kidney disease, heart failure, moderate to severe pulmonary hypertension

Outcomes

Primary Outcomes

Weight, height , BMI

Time Frame: 1 year

Weight in kg and height in cm to allow BMI measurement weight (kg) / height (m2)

Postoperative pain score

Time Frame: 1 year

Postoperative pain score at rest, hemodynamic effects, analgesic consumption

Study Sites (1)

Loading locations...

Similar Trials